ARCHIVES

NCI to Ask Cancer Panel, NCAB, to Help Respond To Request for Review Of National Cancer Program

This article is from The Cancer Letter archive.

Vol. 18 No. 47 | December 4, 1992

Download PDF Visit The Full Archive

Related Articles

Science Policy: Increased Cancer Death Rate For Atomic Vets Not Significant, OIM Says

October 29, 1999

FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate.

May 28, 2004

OSCC Groups Send Four Concepts To NCI Board

September 13, 1985

Also ASCO to release abstracts to members prior to annual meeting.

January 30, 2004

Feinstein Introduces New Cancer Act; Groups Say Bill Flawed

March 15, 2002

ASCO Recommends Aromatase Inhibitors As Adjuvant For Some Breast Cancer

July 30, 2010